Sinopharm (company)
Search results
Fosun Pharma is a Chinese-based company that develops and produces innovative drugs, vaccines, medical devices, and healthcare services. It has a strong presence in the global market, with products such as Artesun, Han Li Kang, Yi Kai Da, and COMIRNATY, and a MSCI ESG rating of A.
- News
News - Home_Fosun Pharma
- Leadership
Fosun Pharma is patient-centered and clinical...
- Investors
Fosun Pharma will actively promote the digital and physical...
- Job Applicants
Job Applicants - Home_Fosun Pharma
- Contact
Contact - Home_Fosun Pharma
- R&D
Fosun Pharma connects with global excellent scientific...
- Sustainability
Fosun Pharma improves the research and clinical development...
- About Company_Our Company_Fosun Pharma
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co.,...
- News
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ( trade name: Fosun Pharma) is a Chinese pharmaceutical company. It is mostly owned by Fosun International. [2] As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. [3] The company was ranked 1,840th in 2020 edition of the Forbes ...
- 1994
- pharmaceutical, medical
- Shanghai, China
- Fosun High Technology, Guangxin Technology, and 3 others
Fosun Pharma USA is a subsidiary of Fosun Pharma, a leading player in China. It focuses on building a fully integrated biopharmaceutical company in the US market, partnering with late development stage or commercial stage products for unmet medical needs.
Fosun is a Chinese conglomerate that operates in various industries, including pharma. Fosun Pharma was founded in 1994 and listed on the Shanghai Stock Exchange in 1998. See the timeline of Fosun's milestones and achievements.
People also ask
Who owns Shanghai Fosun Pharmaceutical?
What does Fosun Pharma do?
How is Fosun Pharma a global company?
Who is the CEO of Fosun Pharma?
As a joint venture between Shanghai Fosun Pharmaceutical (Group) Co., Ltd and Kite, a Gilead company in U.S., Fosun Kite is dedicated to the advancement of cell therapy and its commercialization to benefit cancer patients in China. Fosun Kite has a commercial manufacturing facility of approximately 10,000 m2, and a R&D center of 2,000 m2 with a ...
Innovative R&D is the core driver for sustainable growth of Fosun Pharma. The Group had built in-house R&D, co-development, in-licensing and incubation capabilities and had established platforms for small molecule innovative drugs, antibody drugs and cell therapy products, focusing on major therapeutic areas, including oncology, immunology, metabolism and digestive system, and central nervous ...
